---
title: 'Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world
  experience from the compassionate use program in Germany'
date: '2024-02-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38377774/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240221170659&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: First results from a real-world population confirm promising
  efficacy of sotorasib for the treatment of advanced KRAS p.G12C-mutated NSCLC. Patients
  with co-occurring KEAP1 mutations seem to derive less ...'
disable_comments: true
---
CONCLUSION: First results from a real-world population confirm promising efficacy of sotorasib for the treatment of advanced KRAS p.G12C-mutated NSCLC. Patients with co-occurring KEAP1 mutations seem to derive less ...